Drug prescription for attention deficit hyperactivity disorder drugs in pediatric outpatients: A retrospective survey of Japanese administrative data (2012-2018).
Sign Up to like & getrecommendations! Published in 2021 at "Asian journal of psychiatry"
DOI: 10.1016/j.ajp.2020.102512
Abstract: We aimed to clarify the prescription trend of ADHD drugs in Japanese pediatric outpatients. From January 2012 to December 2018, we evaluated the trends of prescribing methylphenidate-osmotic-controlled release oral delivery system (OROS), atomoxetine, and guanfacine… read more here.
Keywords: oros atomoxetine; methylphenidate oros; pediatric outpatients; guanfacine ... See more keywords
Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Toxicology"
DOI: 10.1080/15563650.2019.1605076
Abstract: Abstract Introduction: The purpose of this study was to characterize the frequency, reasons for exposure, clinical manifestations, treatments, duration of effects, and medical outcomes of pediatric guanfacine exposures reported to the National Poison Data System… read more here.
Keywords: guanfacine exposures; guanfacine; effect; exposures reported ... See more keywords
Botulinum Toxin Therapy of Social Anxiety Disorder: A Case Series.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001066
Abstract: DISCUSSION Guanfacine may suppress rapid eye movement sleep, modulate sleep architecture, and can result in less sleepwalking. As a selective α-adrenergic 2A agonist, it has the ability to regulate glutamatergic and catecholamine systems, both implicated… read more here.
Keywords: guanfacine; toxin therapy; case; therapy social ... See more keywords